Does HUMAN C1-ESTERASE INHIBITOR Cause Mobility decreased? 434 Reports in FDA Database

Q: Does HUMAN C1-ESTERASE INHIBITOR cause Mobility decreased?

434 reports of Mobility decreased have been filed with the FDA for HUMAN C1-ESTERASE INHIBITOR, representing 3.0% of all HUMAN C1-ESTERASE INHIBITOR adverse event reports.

Q: How dangerous is Mobility decreased from HUMAN C1-ESTERASE INHIBITOR?

Of 434 reports, 422 (97.2%) resulted in death and 385 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 434 reports of Mobility decreased have been filed in association with HUMAN C1-ESTERASE INHIBITOR (Cinryze). This represents 3.0% of all adverse event reports for HUMAN C1-ESTERASE INHIBITOR.

434

Reports of Mobility decreased with HUMAN C1-ESTERASE INHIBITOR

3.0%

of all HUMAN C1-ESTERASE INHIBITOR reports

422

Deaths

385

Hospitalizations

How Dangerous Is Mobility decreased From HUMAN C1-ESTERASE INHIBITOR?

Of the 434 reports, 422 (97.2%) resulted in death, 385 (88.7%) required hospitalization, and 383 (88.2%) were considered life-threatening.

Is Mobility decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HUMAN C1-ESTERASE INHIBITOR. However, 434 reports have been filed with the FAERS database.

What Other Side Effects Does HUMAN C1-ESTERASE INHIBITOR Cause?

Hereditary angioedema (5,572) No adverse event (1,660) Off label use (1,614) Drug ineffective (1,426) Intentional product use issue (1,117) Product use in unapproved indication (1,003) Weight increased (897) Maternal exposure during pregnancy (869) Pain (822) Condition aggravated (775)

What Other Drugs Cause Mobility decreased?

ADALIMUMAB (8,829) ETANERCEPT (8,321) METHOTREXATE (5,936) ABATACEPT (4,519) TOCILIZUMAB (4,403) LEFLUNOMIDE (4,354) HYDROXYCHLOROQUINE (4,105) RITUXIMAB (4,067) INFLIXIMAB (3,784) TOFACITINIB (3,734)

Which HUMAN C1-ESTERASE INHIBITOR Alternatives Have Lower Mobility decreased Risk?

HUMAN C1-ESTERASE INHIBITOR vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX HUMAN C1-ESTERASE INHIBITOR vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN HUMAN C1-ESTERASE INHIBITOR vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE

HUMAN C1-ESTERASE INHIBITOR Full Profile All Mobility decreased Reports All Drugs Causing Mobility decreased HUMAN C1-ESTERASE INHIBITOR Demographics